Literature DB >> 7014657

Captopril in human blood and breast milk.

R G Devlin, P M Fleiss.   

Abstract

Blood and milk concentrations of captopril, a new antihypertensive agent, were studied in 12 lactating normotensive subjects after the administration of 100 mg captopril tablets on a three times daily regimen for a total of seven doses. Peak blood concentrations (+/- S.E.M.) of captopril after the administration of the seventh 100-mg tablet averaged 713.1 +/- 140.6 ng/ml, as compared to average peak milk concentrations of 4.7 +/- 0.7 ng/ml. Time to peak blood concentrations averaged 1.1 +/- 0.2 hour, while time to peak milk concentrations averaged 3.8 +/- 0.6 hours. The data suggest that the human breast selectively restricts the passage of captopril from blood into milk.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014657     DOI: 10.1002/j.1552-4604.1981.tb01759.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  15 in total

Review 1.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

2.  Quinapril and its metabolite quinaprilat in human milk.

Authors:  E J Begg; R A Robson; S J Gardiner; L J Hudson; P A Reece; S C Olson; E L Posvar; A J Sedman
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

Review 3.  The management challenges of non-preeclampsia-related nephrotic syndrome in pregnancy.

Authors:  Anne Marie Côté; Nadine Sauvé
Journal:  Obstet Med       Date:  2011-07-26

Review 4.  Effect of pregnancy on the pharmacokinetics of antihypertensive drugs.

Authors:  Gail D Anderson; Darcy B Carr
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 5.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 6.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 7.  Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.

Authors:  K L Duchin; D N McKinstry; A I Cohen; B H Migdalof
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of vasodilators. Part I.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

Review 9.  Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.

Authors:  S H Kubo; R J Cody
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

10.  Use of common migraine treatments in breast-feeding women: a summary of recommendations.

Authors:  Susan Hutchinson; Michael J Marmura; Anne Calhoun; Sylvia Lucas; Stephen Silberstein; B Lee Peterlin
Journal:  Headache       Date:  2013-03-06       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.